Should you buy KYNB stock?
Last updated:
Based on market data through , StockInvest.us rates Fibrogen, Inc. (KYNB) as a Sell Candidate with a technical score of -2.14 on its -10 to +10 scale. This is a downgrade from Hold in the previous daily evaluation.
- Sell signal since
- Price since signal Flat 0.00%
- 3-month trend forecast Up 3.51%
- Easy Tracking In The Watchlist
Weaker technical forecast for Fibrogen, Inc. as stock downgraded to Sell Candidate
(Market data through Aug 10, 2026)
The Fibrogen, Inc. stock price fell by -4.13% on the last day (Monday, 10th Aug 2026) from $7.27 to $6.97. During the last trading day the stock fluctuated 4.59% from a day low at $6.97 to a day high of $7.29. The price has been going up and down for this period, and there has been a -1.13% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 thousand shares and in total, 3 thousand shares were bought and sold for approximately $22.89 thousand.
The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.51% during the next 3 months and, with a 90% probability hold a price between $6.99 and $8.01 at the end of this 3-month period.
KYNB Signals & Forecast
There are mixed signals in the stock today. The Fibrogen, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $7.16. On a fall, the stock will find some support from the short-term average at $6.95. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, August 07, 2026, and so far it has fallen -4.13%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Fibrogen, Inc. stock
Fibrogen, Inc. finds support from accumulated volume at $6.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.320 between high and low, or 4.59%. For the last week the stock has had daily average volatility of 3.65%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (KYNB) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Fibrogen, Inc. to open at $7.08, and during the day (based on 14 day Average True Range), to move between $6.84 and $7.10, which gives a possible trading interval of +/-$0.265 (+/-3.88%) up or down from last closing price. If Fibrogen, Inc. takes out the full calculated possible swing range there will be an estimated 3.88% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $6.94 (0.43%) than the resistance at $7.13 (2.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Fibrogen, Inc. will release earnings AMC on Thursday, August 13, 2026.The consensus among the analysts for the expected earnings (EPS) is -$3.18. We will update the financials statements for Fibrogen, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 3.63% in the first trading day after earnings release.
Is Fibrogen, Inc. stock A Buy?
Fibrogen, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.
Current score:
-2.140
Sell Candidate
Downgraded
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $7.08 ( 1.53%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
KYNB Performance
Trading levels for KYNB
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 7.40 | 6.12% |
| R2 | 7.27 | 4.37% |
| R1 | 7.20 | 3.28% |
| Price | 6.97 | |
| S1 | 6.95 | -0.223% |
| S2 | 6.88 | -1.31% |
| S3 | 6.76 | -3.06% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 7.54 | 8.18% |
| R2 | 7.32 | 5.02% |
| R1 | 7.13 | 2.30% |
| Price | 6.97 | |
| S1 | 6.94 | -0.430% |
| S2 | 6.80 | -2.44% |
| S3 | 6.69 | -4.02% |
FAQ
Click here for our free guide on how to buy Fibrogen, Inc. Stock.
Buy KYNB